Scancell strengthens IP with two “important” patent grants in US and Europe The US patent covers Modi-1, while the European patent relates to a monoclonal antibody called FG88 [View article] Wednesday 20 March 2019 11:55 Categories: Media Coverage Modi-1 Moditope Year - 2019
Scancell in vanguard of immuno-oncology advances, with two technologies that show early promise The AIM-listed group is at the vanguard of advances in the emerging field of immuno-oncology and is working on two technologies that are showing early promise [View article] Tuesday 12 February 2019 20:07 Categories: Immunobody Media Coverage Modi-1 Modi-2 SCIB1 SCIB2 Year - 2019
Scancell lauds another six months of progress The funds raised in the last year "will allow us to focus on initiating the planned Phase 2 clinical trial for our lead ImmunoBody, SCIB1, and to advance our Moditope products, Modi-1 and Modi-2, towards the clinic". [View article] Thursday 31 January 2019 13:41 Categories: Immunobody Media Coverage Modi-1 Modi-2 Moditope SCIB1 Year - 2019
Scancell Holdings part of the new cancer revolution The AIM-listed drug developer is at the vanguard of advances in the emerging field of immuno-oncology. [View article] Tuesday 25 September 2018 13:20 Categories: Immunobody Media Coverage Modi-1 Moditope SCIB1 SCIB2 Year - 2018
2018 Preliminary Results To download click here Tuesday 25 September 2018 13:00 Categories: Immunobody Modi-1 Moditope News Regulatory News SCIB1 Year - 2018
Scancell receives European patent protection for immunotherapy platform The patent protects a new class of cancer vaccines rolling off the Moditope platform [View article] Wednesday 23 May 2018 10:28 Categories: Media Coverage Modi-1 Moditope Year - 2018
Scancell unveils funding plans for exciting pipeline of next-generation cancer drugs In a separate announcement, the company said it was acquiring new technology from Nottingham University that will complement its current pipeline [View article] Wednesday 18 April 2018 18:15 Categories: Immunobody Media Coverage Modi-1 Moditope SCIB1 Year - 2018
Proposed Placing, Subscription and Open Offer To download click here Wednesday 18 April 2018 13:00 Categories: Modi-1 News Regulatory News SCIB1 SCIB2 Year - 2018
The PolyPeptide Group appointed to manufacture Scancell’s Modi-1-AMPLIVANT® conjugate To download click here Posted by Scancell Tuesday 3 April 2018 13:00 Categories: Modi-1 Moditope News Regulatory News Year - 2018
Scancell signs manufacturing agreement for its Moditope anti-cancer platform The AIM-listed firm said its Moditope platform acts by stimulating the production of CD4+ T cells, which seek out and kill tumour cells that would otherwise be hidden from the immune system [View article] Tuesday 3 April 2018 10:40 Categories: Media Coverage Modi-1 Moditope Year - 2018